CAROTENUTO, ALFONSO
 Distribuzione geografica
Continente #
AS - Asia 5.526
NA - Nord America 4.973
EU - Europa 4.704
SA - Sud America 773
AF - Africa 158
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 4
Totale 16.145
Nazione #
US - Stati Uniti d'America 4.752
SG - Singapore 3.052
RU - Federazione Russa 2.299
CN - Cina 1.282
IT - Italia 871
BR - Brasile 635
HK - Hong Kong 498
VN - Vietnam 311
DE - Germania 272
FI - Finlandia 227
IE - Irlanda 225
NL - Olanda 194
UA - Ucraina 164
GB - Regno Unito 144
CA - Canada 132
IN - India 96
SE - Svezia 95
AR - Argentina 57
FR - Francia 57
CI - Costa d'Avorio 56
MX - Messico 53
BD - Bangladesh 39
PL - Polonia 37
KR - Corea 36
ZA - Sudafrica 36
JP - Giappone 34
TR - Turchia 33
ES - Italia 26
ID - Indonesia 24
IQ - Iraq 23
BE - Belgio 20
AT - Austria 19
EC - Ecuador 18
CO - Colombia 17
IL - Israele 14
LT - Lituania 10
PY - Paraguay 10
UZ - Uzbekistan 10
BG - Bulgaria 9
EG - Egitto 9
JM - Giamaica 9
PE - Perù 9
VE - Venezuela 9
IR - Iran 8
MA - Marocco 8
PK - Pakistan 8
UY - Uruguay 8
CL - Cile 7
KE - Kenya 7
AZ - Azerbaigian 6
SA - Arabia Saudita 6
AE - Emirati Arabi Uniti 5
DZ - Algeria 5
JO - Giordania 5
NP - Nepal 5
CR - Costa Rica 4
HN - Honduras 4
KZ - Kazakistan 4
OM - Oman 4
PS - Palestinian Territory 4
RO - Romania 4
SN - Senegal 4
TH - Thailandia 4
TT - Trinidad e Tobago 4
AU - Australia 3
BA - Bosnia-Erzegovina 3
ET - Etiopia 3
EU - Europa 3
GA - Gabon 3
GT - Guatemala 3
MD - Moldavia 3
NZ - Nuova Zelanda 3
PA - Panama 3
PT - Portogallo 3
TN - Tunisia 3
TW - Taiwan 3
BB - Barbados 2
BH - Bahrain 2
BO - Bolivia 2
CD - Congo 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
DJ - Gibuti 2
DO - Repubblica Dominicana 2
GR - Grecia 2
LV - Lettonia 2
MG - Madagascar 2
MY - Malesia 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
TZ - Tanzania 2
UG - Uganda 2
YT - Mayotte 2
AD - Andorra 1
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BY - Bielorussia 1
Totale 16.114
Città #
Singapore 1.347
Chandler 585
Moscow 560
Hong Kong 497
Beijing 425
Ashburn 387
Santa Clara 287
Naples 243
Dallas 186
Hefei 183
Amsterdam 182
Millbury 174
Princeton 169
Jacksonville 159
Los Angeles 149
Boston 143
San Jose 133
Nanjing 132
Napoli 115
Ho Chi Minh City 102
Buffalo 75
Munich 74
São Paulo 73
Ottawa 70
New York 67
Wilmington 66
Hanoi 65
Des Moines 62
Redondo Beach 57
Woodbridge 55
Ann Arbor 46
Brooklyn 44
Seattle 42
The Dalles 41
Nanchang 38
Turku 37
Warsaw 35
Houston 33
Denver 32
Seoul 32
Mexico City 31
Shenyang 30
Rome 28
Chicago 27
Helsinki 27
Montreal 25
Hebei 24
Poplar 24
Rio de Janeiro 24
Tokyo 23
Atlanta 22
North Bergen 22
Tianjin 22
Falls Church 21
Frankfurt am Main 21
Orem 21
Stockholm 21
Toronto 21
Chennai 20
Falkenstein 20
Milan 19
Nuremberg 19
Jiaxing 18
San Francisco 18
London 17
Augusta 16
Biên Hòa 16
Boardman 16
Columbus 16
Kronberg 16
Changsha 15
Norwalk 15
Bologna 14
Dong Ket 14
Hangzhou 14
Lawrence 14
Phoenix 14
Ankara 13
Düsseldorf 13
Haiphong 13
Johannesburg 13
Washington 13
Belo Horizonte 12
Charlotte 12
Florence 12
Guangzhou 12
Brussels 11
Da Nang 11
Manchester 11
Brasília 10
Curitiba 10
Dearborn 10
Baghdad 9
Buenos Aires 9
Goiânia 9
Osasco 9
Pune 9
Arce 8
Nakano 8
Ninh Bình 8
Totale 8.192
Nome #
" Molecular Modelingof the Urotensin-II receptor Complex" 218
Functional Selectivity Revealed by N-Methylation Scanning of Human Urotensin II and Related Peptides 205
Antimicrobial peptide Temporin-L complexed with anionic cyclodextrins results in a potent and safe agent against sessile bacteria 165
Screening Platform toward New Anti-HIV Aptamers Set on Molecular Docking and Fluorescence Quenching Techniques 163
Urokinase receptor derived peptides as potent inhibitors of the formyl peptide receptor type 1-triggered cell migration 159
Alanine scanning analysis and structure-function relationships of the frog-skin antimicrobial peptide temporin-1Ta 149
Discovery of 2,3-Diaminoindole Derivatives as a Novel Class of NOD Antagonists 141
Unraveling the active conformation of urotensin II 141
An investigation into the origin of the biased agonism associated with the urotensin II receptor activation 135
A nutraceutical formulation based on Annurca apple polyphenolic extract is effective on intestinal cholesterol absorption: A randomised, placebo-controlled, crossover study 133
Discovery of New Potent Ligands at Human Urotensin-II Receptor 130
Glycine-replaced derivatives of [Pro3,DLeu9]TL, a temporin L analogue: Evaluation of antimicrobial, cytotoxic and hemolytic activities 129
"3D Structural analysis of Urotensin-II analogues in membrane mimetic environment" 129
Exploring the N-Terminal Region of C-X-C Motif Chemokine 12 (CXCL12): Identification of Plasma-Stable Cyclic Peptides As Novel, Potent C-X-C Chemokine Receptor Type 4 (CXCR4) Antagonists 127
Discovery of Novel Potent and Selective Agonists at the Melanocortin-3 Receptor 126
Theoretical and experimental studies on the interaction of biphenyl ligands with human and murine PD-L1: Up-to-date clues for drug design 124
The Outcomes of Decorated Prolines in the Discovery of Antimicrobial Peptides from Temporin-L 124
An ancestral host defence peptide within human β-defensin 3 recapitulates the antibacterial and antiviral activity of the full-length molecule 120
In vitro evaluation of tumor targeting ability of a parenteral enoxaparin-coated self-emulsifying drug delivery system 118
Structure-Activity Study of the Peptides P5U and Urantide by the Development of Analogues Containing Uncoded Amino Acids at Position9 117
D-Amino Acids Containing Temporin L Analogues 115
Structure-Activity Relationships and Biological Characterization of a Novel, Potent, and Serum Stable C-X-C Chemokine Receptor Type 4 (CXCR4) Antagonist 115
Design, synthesis, and conformational analysis of Melanotropin analogues of MTII and SHU9119. 113
Monitoring the effect of antagonist on P53-MDM2 interaction with NMR spectroscopy. Recent results 112
Novel α-MSH peptide analogues with broad spectrum antimicrobial activity. 111
Investigation on side-product formation during the synthesis of a lactoferrin-derived lactam-bridged cyclic peptide 111
Lead Optimization of P5U and Urantide: Discovery of Novel Potent Ligands at the Urotensin-II Receptor 109
Ligand-Based NMR Study of C-X-C Chemokine Receptor Type 4 (CXCR4)-Ligand Interactions on Living Cancer Cells 109
Disulfide bond replacement with 1,4‐ and 1,5‐disubstituted [1,2,3]‐triazole on C‐X‐C chemokine receptor type 4 (CXCR4) peptide ligands: small changes that make big differences 109
Urantide Conformation and Interaction with the Urotensin-II Receptor 108
Breast tumor cell invasion and pro-invasive activity of cancer-associated fibroblasts co-targeted by novel urokinase-derived decapeptides 108
Synthesis and characterization of bis-triazolyl-pyridine derivatives as noncanonical DNA-interacting compounds 107
Visible Light-promoted C(sp3)-H α-Carbamoylation of Cyclic Ethers with Isocyanides 106
Design, Synthesis, and Cytotoxic Evaluation of AcylDerivatives of 3-Aminonaphtho[2,3-b]thiophene-4,9-dione, a Quinone-Based System 105
Design, synthesis and efficacy of novel G protein-coupled receptor kinase 2 inhibitors 105
SAR study and conformational analysis of a series of novel peptide G protein-coupled receptor kinase 2 inhibitors 104
Identification of a Novel p53 Modulator Endowed with Antitumoural and Antibacterial Activity through a Scaffold Repurposing Approach 103
NEW INSIGHT INTO THE BINDING MODE OF CYCLIC MELANOCORTIN LIGANDS AT THE MC4 RECEPTOR 103
Development of Macrocyclic Peptidomimetics Containing Constrained α,α-Dialkylated Amino Acids with Potent and Selective Activity at Human Melanocortin Receptors 103
1H and 15N sequential assignment and secondary structure of the monomeric N67D mutant of bovine seminal ribonuclease 102
New insight into the binding mode of peptides at urotensin-II receptor by Trp-constrained analogues of P5U and urantide. 102
Structures and micelle locations of the nonlipidated and lipidated C-terminal membrane anchor of 2’,3’-cyclic nucleotide-3’-phosphodiesterase 101
Design, Synthesis, and Evaluation of Gluten Peptide Analogs as Selective 401 Inhibitors of Human TG2 101
NMR analysis of synthetic peptides agonist to PTPRJ, a receptor-type protein tyrosine phosphatase with tumor suppressor activity 101
NMR analysis of synthetic peptides agonist to PTPRJ, a receptor-type protein tyrosine phosphatase with tumor suppressor activity. 100
Design, Synthesis, and Conformational Analysis of Melanotropin Analogues of MTII and SHU9119 100
SOLUTION STRUCTURE OF MONOMERIC BOVINE SEMINAL RIBONUCLEASE 99
Design and synthesis of the small libraries of peptidomimetics based on thiazolidine moiety 99
Development of Cyclic Peptide Inhibitors of GRK2 99
Expanding Structure-Activity Relationships of Human Urotensin II Peptide Analogues: A Proposed Key Role of the N-Terminal Region for Novel Urotensin II Receptor Modulators 98
Photomicellar Catalyzed Synthesis of Amides from Isocyanides: Optimization, Scope, and NMR Studies of Photocatalyst/Surfactant Interactions 98
Deepening bis-(thio)carbohydrazones conformational dynamics and hydrogen bond interactions in a non-protic solvent: DFT, molecular dynamics, NMR, and Raman investigations 98
Host Defense Peptide-derived Privileged Scaffolds for Anti-infective Drug Discovery 98
Design and Synthesis of Spirotryprostatin-inspired Diketopiperazine Systemsfrom Prolyl Spirooxoindolethiazolidine Derivatives 97
Novel octreotide dicarba-analogues with high affinity and different selectivity for somatostatin receptors 97
Structure-Activity Relationship, Conformational and Biological Studies of Temporin L Analogues 97
Role of Lipoylation of the Immunodominant Epitope of Pyruvate Dehydrogenase Complex: Toward a Peptide-Based Diagnostic Assay for Primary Biliary Cirrhosis 97
Nondenaturing polyacrylamide gel electrophoresis to study the dissociation of the p53·MDM2/X complex by potentially anticancer compounds 97
HOPPI-NMR: Hot-Peptide-Based Screening Assay for Inhibitors of Protein-Protein Interactions by NMR 97
A novel β-hairpin peptide derived from the ARC repressor selectively interacts with the major groove of B-DNA 97
Conformational study on cyclic melanocortin ligands and new insight into their binding mode at the MC4 receptor 96
Synthesis and pharmacological evaluation of some 4-oxo-quinoline-2-carboxylic acid derivatives as anti-inflammatory and analgesic agents 96
Structure and absolute stereochemistry of the new cyclolinteinol and cyclolinteinol acetate, macrophage activation modulators 96
New Anticancer Agents Mimicking Protein Recognition Motifs. 96
3D structure of monomeric bovine seminal ribonuclease by heteronuclear NMR 95
Unraveling the active conformation of urotensin II 95
Development of Antiviral Fusion Inhibitors: Short Modified Peptides Derived from the Transmembrane Glycoprotein of Feline Immunodeficiency Virus 94
A novel route to synthesize Freidinger lactams by microwave irradiation 94
Structure- and conformation-activity studies of nociceptin/orphanin FQ receptor dimeric ligands 94
Morphicetin analogues containing a new β-turn thiazolidine mimetic 93
Identification of the Spiro(oxindole-3,3’-thiazolidine)-Based Derivatives as Potential p53 Activity Modulators 93
Sar Study Of P5u And Urantide Analogues Modified At Position 9 93
First-in-Class Cyclic Temporin L Analogue: Design, Synthesis, and Antimicrobial Assessment 92
Glucopeptides derived from myelin-relevant proteins and hyperglucosylated nontypeable Haemophilus influenzae bacterial adhesin cross-react with multiple sclerosis specific antibodies: A step forward in the identification of native autoantigens in multiple sclerosis 91
A proteomic approach to characterize a native antigen involved in autoantibody response in multiple sclerosis by a structure-based designed glycopeptide 91
A De Novo Designed Library of Linear Helical Peptides: An Exploratory Tool in the Discovery of Protein-Protein Interaction Modulators 91
Combinatorial Approach in the Synthesis of a Small Library of β-Turn Structures Based on Thiazolidine Moiety 90
A SARS–CoV-2 Spike Receptor Binding Motif Peptide Induces Anti-Spike Antibodies in Mice andIs Recognized by COVID-19 Patients 89
Nuovi peptidi e peptidomimetici come agenti potenti e mirati nella prevenzione e nel trattamento dell’invasione e metastasi tumorali 89
Molecular Modeling of the Urotensin-UT Receptor Complex 89
Structure-Activity Relationship Studies, SPR Affinity Characterization, and Conformational Analysis of Peptides That Mimic the HNK-1 Carbohydrate Epitope 89
A New, Potent Urotensin II Receptor Peptide Agonist Containing a Pen Residue at the Disulfide Bridge 88
SAR Study on CN17β a Potent and Selective CaMKII Peptide Inhibitor 88
Novel cyclic biphalin analogue with improved antinociceptive properties. 88
SAR Study and Conformational Analysis of a Series of Novel GRK2 Peptide inhibitors 88
Synthetic short-chain peptide analogues of H1 relaxin lack affinity for the RXFP1 receptor and relaxin-like bioactivity. Clues to a better understanding of relaxin agonist design 86
Introduction of constrained Trp analogs in RW9 modulates structure and partition in membrane models 86
Solution structure of monomeric bovine seminal ribonuclease 86
Synthesis, in vitro, and in cell studies of a new series of [Indoline-3,2'-thiazolidine]-based p53 modulators. 86
Glioblastoma Cell Migration, Invasion and Vasculogenic Mimicry Downmodulated by Novel uPAcyclin Derivatives 85
Synthesis of a Dicarba-Analog of Octreotide Keeping the Type II Beta-Turn of the Pharmacophore in Water Solution 84
Design, Synthesis, Conformational Analysis, and Biological Studies of Urotensin II Lactam analogues 84
Spiro[(dihydropyrazin-2,5-dione)-6,3’-(2’,3’-dihydrothieno[2,3-b]naphtho-4’,9’-dione)]-Based Cytotoxic Agents: Structure-Activity Relationship Studies on the Substituent at N4-Position of the Diketopiperazine Domain 83
UT RECEPTOR LIGANDS. SWITCHING FROM AGONIST TO ANTAGONIST ACTIVITY 82
Porrigenins A and B, novel cytotoxic and antiproliferative sapogenins isolated from Allium porrum 82
Design, synthesis, and evaluation of gluten peptide analogs as selective inhibitors of human TG2 80
Stereostructures of new bioactive sesterterpenes isolated from the Caribbean sponge Cacospongia cf. linteiformis 80
D-Amino Acids Containing Temporin L Analogues 79
THE FLAVONOIDS OF ALLIUM URSINUM 78
Conformation-Activity Relationship of Designed Glycopeptides as Synthetic Probes for the Detection of Autoantibodies, Biomarkers of Multiple Sclerosis 78
Totale 10.521
Categoria #
all - tutte 55.083
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.083


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021218 0 0 0 0 0 0 36 14 47 22 75 24
2021/20221.035 25 7 12 26 19 22 16 27 234 81 121 445
2022/20231.359 198 102 54 127 153 149 9 121 192 169 62 23
2023/2024989 55 139 171 56 64 93 15 127 13 16 174 66
2024/20255.222 254 307 56 73 83 314 508 328 472 565 1.799 463
2025/20265.871 1.099 748 1.045 920 1.493 394 172 0 0 0 0 0
Totale 16.489